|
Jason Dwyer, an assistant chemistry professor at the University of Rhode Island, has been awarded a five-year, $400,000 research grant from the National Science Foundation.
more
By Emily Greenhalgh |
|
Covidien PLC has received 510(k) clearance from the U.S. Food and Drug Administration to use its LigaSure curved, small jaw, open sealer/divider in ear, nose and throat procedures.
more
By PBN Staff
|
|
A new study by Dr. Frank Sellke at Rhode Island has found that consuming red wine has more benefits than consuming vodka for pigs with high cholesterol.
more
By Richard Asinof |
|
East Providence biomedical company ProThera Biologics LLC - led by Rhode Island Hospital scientists Dr. Yow-Pin Lim, above, and Douglas Hixson - has received $750,000 in new funding from the National Institutes of Health and Slater Technology Fund.
more
By Patrick Anderson |
|
The University of Rhode Island is set to celebrate the opening of its newly completed $75 million building for the College of Pharmacy on Tuesday, Sept. 4 at 11 a.m.
more
By PBN Staff
|
|
EpiVax Inc., led by founder and CEO Dr. Anne S. De Groot, has been awarded an additional $300,000 Small Business Innovation Research grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, the company announced Friday.
more
By Emily Greenhalgh |
|
Medical device maker Covidien PLC landed 501(k) clearance by the U.S. Food and Drug Administration for its reusable iDrive Ultra powered stapling system.
more
By Emily Greenhalgh |
|
Profit for Astro-Med Inc. dropped 5.6 percent to $987,000, or 13 cents per diluted share, during the second quarter of 2012, compared with $1.05 million, or 14 cents per diluted share, during the second quarter of 2011.
more
|
|
Medical technology maker Covidien Ltd. has officially opened its Shanghai-based research and development facility, the China Technology Center, the company announced Thursday.
more
By Emily Greenhalgh |
|
Medical technology maker Covidien Plc. reported third quarter earnings of $453 million, or 93 cents per diluted share, a drop of 15.3 percent from the $535 million, or $1.07 per diluted share reported during the same period in 2011.
more
By PBN Staff
|